MDRNA, Inc. (MRNA.O)
MRNA.O on Consolidated Issue listed on NASDAQ Global Market
0.91USD
9:53am EST
0.91USD
9:53am EST
Price Change (% chg)
$0.02 (+2.25%)
$0.02 (+2.25%)
Prev Close
$0.89
$0.89
Open
$0.87
$0.87
Day's High
$0.93
$0.93
Day's Low
$0.86
$0.86
Volume
24,137
24,137
Avg. Vol
170,811
170,811
52-wk High
$3.55
$3.55
52-wk Low
$0.21
$0.21
About
MDRNA, Inc. (MDRNA) is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (RNAi). The Company’s infrastructure provides for pre-clinical scale manufacturing of both siRNAs and delivery materials, the comprehensive analysis and optimization of these... (more)
Overall
| Beta: | 2.51 |
| Market Cap (Mil.): | $37.13 |
| Shares Outstanding (Mil.): | 40.81 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| MRNA.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 3.56 | 4.64 |
| EPS (TTM): | 73.81 | -- | -- |
| ROI: | -234.60 | 1.78 | 2.79 |
| ROE: | -- | 2.39 | 3.51 |
Competitors
| Price | Change | |
|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA.TA) | ₪20,120.00 | -80.00 |
| Javelin Pharmaceuticals Inc. (JAV.A) | $1.37 | +0.14 |
| AstraZeneca plc (AZN.L) | £2,825.50 | +7.50 |
| GlaxoSmithKline plc (GSK.L) | £1,298.00 | +1.00 |
| Johnson & Johnson (JNJ.N) | $64.34 | -0.13 |
| Alkermes, Inc. (ALKS.OQ) | $8.85 | +0.02 |
| Alkermes, Inc. (ALKSP.OQ) | -- | -- |
| Nektar Therapeutics (NKTR.OQ) | $8.73 | +0.07 |
| SkyePharma PLC (SKP.L) | £85.25 | -1.25 |
| Unigene Laboratories (UGNE.OB) | $-- | -- |





Earnings vs
Estimates